{
    "id": 3647,
    "fullName": "DDR2 L63V",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "DDR2 L63V lies within the discoidin domain of the Ddr2 protein (PMID: 22328973). L63V confers a gain of function to the Ddr2 protein, as demonstrated by increased Stat5 and Src phosphorylation (PMID: 22328973), elevated phosphorylation of Ddr2, and transformation activity in cell culture (PMID: 28161936).",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                },
                {
                    "id": 10579,
                    "pubMedId": 28161936,
                    "title": "Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28161936"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4921,
        "geneSymbol": "DDR2",
        "terms": [
            "DDR2",
            "MIG20a",
            "NTRKR3",
            "TKT",
            "TYRO10",
            "WRCN"
        ]
    },
    "variant": "L63V",
    "createDate": "03/10/2015",
    "updateDate": "06/07/2019",
    "referenceTranscriptCoordinates": {
        "id": 147415,
        "transcript": "NM_001014796",
        "gDna": "chr1:g.162754625C>G",
        "cDna": "c.187C>G",
        "protein": "p.L63V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5096,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sprycel (dasatinib) inhibited growth of transformed cells expressing DDR2 L63V in culture (PMID: 22328973).",
            "molecularProfile": {
                "id": 3448,
                "profileName": "DDR2 L63V"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5117,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Saracatinib (AZD0530) with Tasigna (nilotinib) reduced Src and Stat5 activation and inhibited proliferation of transformed cells expressing DDR2 L63V in culture, with increased potency over either agent alone (PMID: 22328973).",
            "molecularProfile": {
                "id": 3448,
                "profileName": "DDR2 L63V"
            },
            "therapy": {
                "id": 3756,
                "therapyName": "Nilotinib + Saracatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5108,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited growth of transformed cells expressing DDR2 L63V in culture (PMID: 22328973).",
            "molecularProfile": {
                "id": 3448,
                "profileName": "DDR2 L63V"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1802,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sprycel (dasatinib) prevented colony formation and induced cell death in lung squamous cell carcinoma cells expressing DDR2 L63V in culture (PMID: 22328973).",
            "molecularProfile": {
                "id": 3448,
                "profileName": "DDR2 L63V"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 3907,
                "name": "lung squamous cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 141,
                    "pubMedId": 22328973,
                    "title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22328973"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5302,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a lung adenocarcinoma cell line with loss of TP53, MYCN over expression, and harboring DDR2 L63V demonstrated greater inhibition of tumor growth in xenograft models when treated with the combination of Sprycel (dasatinib) and JQ1 compared to either therapy alone (PMID: 26206333).",
            "molecularProfile": {
                "id": 20483,
                "profileName": "DDR2 L63V MYCN over exp TP53 loss"
            },
            "therapy": {
                "id": 3824,
                "therapyName": "Dasatinib + JQ1",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5000,
                    "pubMedId": 26206333,
                    "title": "NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26206333"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3448,
            "profileName": "DDR2 L63V",
            "profileTreatmentApproaches": [
                {
                    "id": 1218,
                    "name": "DDR2 inhibitor",
                    "profileName": "DDR2 L63V"
                }
            ]
        },
        {
            "id": 20483,
            "profileName": "DDR2 L63V MYCN over exp TP53 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 147415,
            "transcript": "NM_001014796",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147411,
            "transcript": "XM_006711344",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147414,
            "transcript": "XM_011509588",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147413,
            "transcript": "XM_011509587",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147412,
            "transcript": "XM_011509586",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 147416,
            "transcript": "NM_006182",
            "gDna": "chr1:g.162754625C>G",
            "cDna": "c.187C>G",
            "protein": "p.L63V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}